Named in memory of Kirsten Sandstrom, Kirsten's Legacy is TGen's research and clinical program for defeating Adrenocortical Carcinoma (ACC).

TGen, the Translational Genomics Research Institute, is a non-profit Phoenix, Arizona, based institute that employs a number of todays leading genomic researchers studying many types of cancer, including ACC.

ACC is rare: less than 2 individuals in 1 million are affected. When the numbers are that low, few federal or philanthropic dollars flow toward studying the causes or finding a cure. That means fewer advances in diagnoses or therapeutic treatments.